Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.

@article{Froestl2012CognitiveE,
  title={Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.},
  author={W. Froestl and A. Muhs and A. Pfeifer},
  journal={Journal of Alzheimer's disease : JAD},
  year={2012},
  volume={32 4},
  pages={
          793-887
        }
}
  • W. Froestl, A. Muhs, A. Pfeifer
  • Published 2012
  • Medicine, Psychology
  • Journal of Alzheimer's disease : JAD
  • Cognitive enhancers (nootropics) are drugs to treat cognition deficits in patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging. Cognition refers to a capacity for information processing, applying knowledge, and changing preferences. It involves memory, attention, executive functions, perception, language, and psychomotor functions. The term nootropics was coined in 1972 when memory enhancing properties of piracetam were observed… CONTINUE READING
    Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
    23
    Neurotransmitters and Memory
    3
    Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014.
    14
    Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 1,716 REFERENCES
    Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
    23
    Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.
    13
    Metabotropic glutamate receptors as therapeutic targets for cognitive disorders.
    38